EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamic effects of radioactive iodine therapy on gut microbiota and metabolites in patients with papillary thyroid cancer

Yuhui Cao iD, Xi Zhang, Jie Tan, Yuqi Wang, Qian Guo, Yuan Gao, Jinzhi Chen, Yulong Chen, Keting Tong, Zijian Fu, Linlin Ma, Caixia Wu und 4 weitere

Microbiology Spectrum · 04.08.2026 · 14 (8)

DOI: 10.1128/spectrum.03237-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Yuhui Cao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Bacteria, Gastrointestinal Microbiome, Iodine Radioisotopes, Thyroid Cancer, Papillary. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, National High-Level Hospital Clinical Research Funding (Interdepartmental Clinical Research Project of Peking University First Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dynamic characteristics of gut microbiome and metabolome during radiopharmaceutical therapy and their correlation with treatment response have not been well clarified. Herein, we conducted a prospective longitudinal study on papillary thyroid carcinoma patients receiving initial radioactive iodine (RAI) treatment. Three fecal samples from each patient were sequentially collected at the day before (Day0), 3 days upon (Day3), and 30 days upon (Day30) receiving RAI (totally 75 samples) for 16S rRNA amplicon sequencing and metabolome profiling. The results revealed transient fluctuations of gut microbiota and metabolites during RAI treatment, as shown by probiotic Blautia and anti-inflammatory and antioxidant metabolites first decreased on Day3 and then increased on Day30, while the opposite trends of opportunistic pathogens Streptococcus were observed. Meanwhile, correlation analysis showed a complex interplay between the temporal alterations of Blautia and the anti-inflammatory and antioxidant metabolites. Furthermore, the variability of intestinal flora and metabolites at multiple time points corresponded to the response to RAI treatment. In conclusion, our findings indicated that internal irradiation could lead to transient fluctuations of gut microbiota and metabolites, suggesting that probiotics might be beneficial for patients receiving RAI. Additionally, we provided a new perspective to screen for noninvasive biomarkers corresponding to the response to RAI treatment. IMPORTANCE This study provides the first longitudinal profiling demonstrating that radioactive iodine (RAI) therapy induces transient yet dynamic fluctuations in both the gut microbiome and metabolome. Key beneficial bacteria and anti-inflammatory metabolites were significantly reduced immediately after treatment, followed by a recovery trend. Moreover, patients with different treatment responses showed diverse microbial and metabolic profiles. These findings highlight the potential for probiotic based interventions to maintain gut ecological homeostasis and suggest novel non invasive microbial biomarkers for predicting RAI efficacy. This study is registered with ClinicalTrials.gov as ChiCTR2100053810 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaGastrointestinal MicrobiomeIodine RadioisotopesThyroid Cancer, PapillaryThyroid NeoplasmsAdultFemaleHumansMaleMiddle AgedFecesLongitudinal StudiesMetabolomeProbioticsProspective StudiesRNA, Ribosomal, 16S

Stichwörter der Autor:innen

gut microbiotametabolismpapillary thyroid carcinomaradiation perturbationradioactive iodine therapytreatment response

Substanzen

Iodine RadioisotopesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Department of Biomedical Engineering, College of Future Technology, and Center for Quantitative Biology, Peking University, Beijing, China.
  • Department of Nuclear Medicine, The Second Affiliated Hospital of Anhui Medical University, Anhui, China.

ORCID-Profile: Yuhui Cao, Xiaoxi Pang, Meng Liu, Huaiqiu Zhu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality
  • National High-Level Hospital Clinical Research Funding (Interdepartmental Clinical Research Project of Peking University First Hospital)
  • Clinical Research Cultivation Program of The Second Affiliated Hospital of Anhui Medical University

Zitieren

APA

Cao, Y., Zhang, X., Tan, J., Wang, Y., Guo, Q., Gao, Y., Chen, J., Chen, Y., Tong, K., Fu, Z., Ma, L., Wu, C., Li, F., Pang, X., Liu, M., & Zhu, H. (2026). Dynamic effects of radioactive iodine therapy on gut microbiota and metabolites in patients with papillary thyroid cancer. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.03237-25

Vancouver

Cao Y, Zhang X, Tan J, Wang Y, Guo Q, Gao Y, et al. Dynamic effects of radioactive iodine therapy on gut microbiota and metabolites in patients with papillary thyroid cancer. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.03237-25

BibTeX
@article{Cao2026,
  author = {Cao, Yuhui and Zhang, Xi and Tan, Jie and Wang, Yuqi and Guo, Qian and Gao, Yuan and Chen, Jinzhi and Chen, Yulong and Tong, Keting and Fu, Zijian and Ma, Linlin and Wu, Caixia and Li, Fei and Pang, Xiaoxi and Liu, Meng and Zhu, Huaiqiu},
  title = {Dynamic effects of radioactive iodine therapy on gut microbiota and metabolites in patients with papillary thyroid cancer},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1128/spectrum.03237-25}
}
Kostenlos starten →